Spero Therapeutics News

Spero Therapeutics | 8-K: Spero Therapeutics Announces First Quarter 2024 Operating Results and Provides a Business Update

May 15 16:19 ET

Spero Therapeutics | DEFA14A: Others

Apr 16 16:21 ET

Spero Therapeutics | DEF 14A: Definitive information statements

Apr 16 16:17 ET

Spero Therapeutics | 8-K: Current report

Mar 29 16:17 ET

Spero Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Mar 15 16:42 ET

Spero Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 15 16:24 ET

Spero Therapeutics | 8-K: Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update

Mar 13 16:11 ET

Spero Therapeutics | 8-K: Current report

Feb 9 16:12 ET

Spero Therapeutics | 8-K: Current report

Jan 8 00:00 ET

Spero Therapeutics | 8-K: Current report

Jan 5 00:00 ET

Spero Therapeutics | 8-K: Current report

Jan 2 00:00 ET

Spero Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Nov 13, 2023 16:50 ET

Spero Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Nov 13, 2023 16:45 ET

Spero Therapeutics | 8-K: Spero Therapeutics Announces Third Quarter 2023 Operating Results and Provides a Business Update

Nov 13, 2023 16:13 ET

Spero Therapeutics | 8-K: Current report

Nov 1, 2023 08:10 ET

Spero Therapeutics | 8-K/A: Current report (Amendment)

Oct 16, 2023 16:01 ET

Spero Therapeutics | 8-K: Current report

Oct 10, 2023 08:28 ET

Spero Therapeutics | DEF 14A: Definitive information statements

Sep 1, 2023 16:08 ET

Spero Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Aug 22, 2023 17:27 ET

Spero Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 10, 2023 16:25 ET